Seek Labs Takes First Place in BioTech and Therapeutics at 2026 Utah Business Innovation Awards

Seek Labs has been named the first-place winner in the BioTech and Therapeutics category of the 2026 Utah Business Innovation Awards, recognizing the company’s work to develop a new approach to therapeutic discovery and development.

Presented by Utah Business, the Innovation Awards recognize organizations and individuals advancing innovative products, services, and technologies across Utah. Seek Labs received first place in the BioTech and Therapeutics category for Sequence Ablation Therapeutics (SAT), the company’s novel therapeutic modality designed to precisely target and ablate disease-driving genetic sequences.

The award reflects growing recognition of Seek Labs’ work at the intersection of artificial intelligence, genomics, CRISPR, and infectious disease preparedness, as well as the company’s broader effort to rethink how quickly new therapeutic interventions can be designed in response to emerging and evolving threats. Learn more about SAT.

Seek Labs is proud to be part of Utah’s growing life sciences community and to be recognized alongside organizations advancing innovation across the state.

Seek Labs’ SAT programs are investigational and currently under development.